Method for diagnosing myocardial infarction

Details Method for diagnosing myocardial infarction Method for diagnosing myocardial infarction

2005-11-17

2010-10-26

Myers, Carla (Department: 1634)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C536S023500, C536S024310

Reexamination Certificate

active

07820383

ABSTRACT:
The kits and methods of the present invention relate to the diagnosis of cardiovascular disorders. In one aspect, the invention discloses a method and a kit for determining whether a subject has a fragile plaque disorder. In one aspect, the invention discloses a method and a kit for determining whether the subject has an occlusive disorder. In one aspect, the invention discloses a method and a kit for determining whether the subject has a restenosis disorder. Other methods of the present invention relate to the selection of therapeutics for a patient with a cardiovascular disease.

REFERENCES:
patent: 4582788 (1986-04-01), Erlich
patent: 4623619 (1986-11-01), Owerbach et al.
patent: 4666828 (1987-05-01), Gusella
patent: 4801531 (1989-01-01), Frossard
patent: 4965188 (1990-10-01), Mullis et al.
patent: 4968607 (1990-11-01), Dower et al.
patent: 5110920 (1992-05-01), Erlich
patent: 5268267 (1993-12-01), Smith
patent: 5554509 (1996-09-01), Collucci et al.
patent: 5658729 (1997-08-01), Hayden et al.
patent: 5686246 (1997-11-01), Kornman et al.
patent: 5698399 (1997-12-01), Duff et al.
patent: 6140047 (2000-10-01), Duff et al.
patent: 6210877 (2001-04-01), Francis et al.
patent: 6268142 (2001-07-01), Duff et al.
patent: 6524795 (2003-02-01), Francis et al.
patent: 6706478 (2004-03-01), Duff et al.
patent: 6720141 (2004-04-01), Crossman et al.
patent: 2003/0152947 (2003-08-01), Crossman et al.
patent: 738875 (1998-09-01), None
patent: 780318 (2000-12-01), None
patent: 782836 (2000-12-01), None
patent: 2282746 (1998-09-01), None
patent: 2374916 (2000-11-01), None
patent: 1255948 (2000-06-01), None
patent: 0983381 (2007-12-01), None
patent: 69838250 (2008-05-01), None
patent: 0609059 (1994-08-01), None
patent: 0269260 (1998-01-01), None
patent: 1192279 (2008-03-01), None
patent: 2156843 (2001-08-01), None
patent: 2311459 (2009-02-01), None
patent: 9840517 (1998-09-01), None
patent: WO 98/40517 (1998-09-01), None
patent: 98/54359 (1998-12-01), None
patent: 00/71753 (2000-11-01), None
patent: WO 00/72015 (2000-11-01), None
patent: WO 02/103031 (2002-12-01), None
patent: WO 03/044176 (2003-05-01), None
patent: WO 2005/108619 (2005-11-01), None
patent: 2007061906 (2007-05-01), None
Hirschhorn et al. Genetics in Medicine. 2002. 4(2): 45-61.
Lucentini, J. The Scientist. Dec. 2004, p. 20.
Halushka et al. Nature. Jul. 1999. 22: 239-247.
Rosenmann et al. Neuroscience Letters. 2004. 363: 131-133.
Francis et al. et al. Heart. 2001. 86: 336-340.
Greestein et al. JADA. 2002. 133: 452-459.
Lloyd-Jones et al. JAMA. May 2004. 291: 2204-2211.
Alexander, R.W.N.E.J.M., 331(7):468-469 (1994).
Anderson et al.Am Heart J., 123(5):1312-1323 (1992).
Badimon et al.Circulation(Suppl. II), 87(3):II3-II16 (1993).
Berger et al.Cytokine., 17(4):171-174 (2002).
Clark et al.Nucl. Acids Res., 14(20):7897-7914 (1986); Erratum inNucl. Acids Res., 15(2):868 (1987).
Clay et al.Hum. Genet., 94:407-410 (1994).
Clay et al.Hum. Genet., 97(6):723-726 (1996).
Cox et al.Am. J. Hum. Genet., 62:1180-1188 (1998).
Di Giovine et al.Hum. Mol. Genet., 1(6):450 (1992).
Dinarello et al.JAMA, 269(14):1829-1835 (1993).
Dinarello et al.N.E.J.M., 328(2):106-113 (1993).
DuffThe Cytokine Handbook, 2ndEd., Chapter 2, pp. 21-30 (1994).
Eklund et al.Eur. Cytokine Netw., 14(3):168-171 (2003).
Francis et al.Circualtion, 99(7):861 (1999).
Galea et al.Ath. Thromb. Vasc. Biol., 16(8):1000-1006 (1996).
GenBank Accession No. X04500 (1997).
GenBank Accession No. X64532 (2004).
GenBank Accession No. X77090 (1996).
GenBank Accession No. Z17008 (1994).
GenBank Accession No. Z16545 (1994).
GIBCO BRL,Product Catalog and Reference Guide, pp. 18-15 to 18-16 (1995/1996).
Hall et al.Arthritis Rheum., 50(6):1976-1983 (2004).
Hasdai et al.Heart, 76:24-28 (1996).
Iacoviello et al.Arterioscler. Thromb. Vasc. Biol., 25:222-227 (2005).
Jaenisch, R.PNAS, 73(4):1260-1264 (1976).
Jähner et al.Nature, 298:623-628 (1982).
Jähner et al.PNAS, 82:6927-6931 (1985).
KnoxHouston Chronicle, “Discovery May Help Battle Heart Attacks” (Jan. 10, 1996).
Kornman et al.J. Periodont. Res., 34:353 (1999).
Latkovskis et al.Eur. J. Immunogenet., 31(5):207-213 (2004).
Libby, P.Circulation, 91(11):2844-2850 (1995).
Liuzzo et al.N.E.J.M., 33(7):417-424 (1994).
Mansfield et al.Gastroenterol., 106(2):637-642 (1994).
McConnell et al.Science, 257:1906-1912 (1992).
Munro et al.Lab. Invest., 58(3):249-261 (1988).
Nicklin et al.Genomics, 19:382-384 (1994).
Pankow et al. 71stEAS Congress and Satellite Symposia, p. 124 (1999).
Russell, R.Nature, 362:801-809 (1993).
Stewart et al.EMBO J., 6(2):383-388 (1987).
Tarlow et al.Hum. Genet., 91:403-404 (1993).
Tarlow et al.J. Invest. Dermatol., 103:387-390 (1994).
Van der Putten et al.PNAS, 82:6148-6152 (1985).
Database GenBank (online), ss44355203, retrieved from GENBANK accession No. rs1143633, Abstract, Jul. 18, 2005.
Muraki et al, “Polymorphisms of IL-1μ Gene in Japanese Patients with Sjögren's Syndrome and Systemic Lupus Erythematosus”,J. Rheumatol., 31(4):720-725 (2004).
International Search Report for PCT/US2006/044793, mailed May 21, 2007.
Examination Report, Application No. EP 00937731.8, Date: Sep. 30, 2005.
Examination Report, Application No. EP 00937731.8, Date: Jan. 19, 2004.
Examination Report, Application No. EP 00939389.3, Date: Nov. 16, 2006.
Examination Report, Application No. EP 00939389.3, Date: Nov. 25, 2004.
Examination Report, Application No. EP 00939389.3, Date: Aug. 1, 2003.
Examination Report, Application No. EP 06837989.0, Date: Dec. 5, 2008.
Examination Report, Application No. EP 98910298.3, Date: Nov. 11, 2005.
Examination Report, Application No. EP 98910298.3, Date: Apr. 19, 2005.
Examination Report, Application No. EP 98910298.3, Date: Aug. 17, 2004.
Examination Report, Application No. EP 08015454.5, Date: May 25, 2009.
Blacmore et al. (1996), Interleukin-1 Receptor Antagonist Allele (IL1 RN*2) Associated with Nephropathy in Diabetes Mellitus, Hum. Genet, 97:369-374.
Kastrati et al., (2000), Protective Role Against Restenosis from an Interleukin-1 Receptor Antagonist Gene Polymorphism in Patients Treated With Coronary Stenting, J. Am. College of Cardiol. 36(7):2168-2173.
Kornman et al., (1999), Interleukin-1 Genotypes and the Association Between Periodontitis and Cardiovascular Disease, J. Periodont. Res., 34:353-357.
Muraki et al., (2004), Polymorphisms of IL-1 beta gene in Japanese Patients with Sjorgren's Syndrome and Systemic Lupus Erythematosus, J. of Rheumatol. 31(4):720-725.
Zee et al., (1999), Genetic Risk Factors for Post-PTCA Restenosis: A Comprehensive Analysis of Multiple Candidate Genes. J. of Am. Heart Assoc. Abstracts from the 72nd Scientific Session. Abstract 3985.
Databasee Genbank Accession No. rs1143633, Jul. 18, 2005.
Examination Report, Application No. EP 00937731.8, Date: Sep. 25, 2006.
Kastrati et al., (2000), Protection Against Restenosis From an Interleukin-1 Receptor Antagonist Gene Polymorphism in Patients Treated with Coronary Stenting, J. Am. College of Cardiol. 35(2):36A (Abstract).
Furutani et al. (1986), Nucleic Acid Research, 14:3167-3179.

Affiliated with

Also associated with

Rating

Method for diagnosing myocardial infarction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for diagnosing myocardial infarction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for diagnosing myocardial infarction will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4217287